Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)

Table 1 Best response with R-Dox.

Response Category	Complete Response	Partial Response	Stable Disease
Clinical	12 (100%)	-	-
Biochemical	10 (83%)	1 (8%)	1 (8%)
Radiographic	6 (50%)	6 (50%)	-
Overall	3 (25%)	6 (50%)	3(25%)

ISSN: 1750-9378